Target Ovarian Cancer has been awarded a sector-first grant to help transform the lives of women with ovarian cancer.
11 women die every day from ovarian cancer, and the disease is notorious for being caught late when it is more advanced and harder to treat. Now a grant from the Peter Sowerby Foundation will enable the charity to tackle early diagnosis of the disease in a radically new way.
Just 42 per cent of women with ovarian cancer are diagnosed early and the national picture is one of significant variation, with nearly twice as many women diagnosed with stage I or II disease in some Clinical Commissioning Groups (CCGs) compared to others. By simply diagnosing more women earlier, an additional 2,000 lives could be saved every year.
There are three barriers to increasing the number of women diagnosed early: the public’s lack of awareness of the symptoms of ovarian cancer, GPs’ understanding of the disease, and issues in the diagnostic pathway itself. It is issued in all three of these areas that lead to delays in diagnosis and differences across the country. Target Ovarian Cancer’s ambitious new project will target all three of these key delays in diagnosis to eradicate the postcode lottery across the UK.
The first stage of the project will be to work with a range of CCGs to develop an in-depth understanding of ovarian cancer diagnoses in their area – what works well and what isn’t working. The results will be used in a nationwide project to work with CCGs and speed up ovarian cancer diagnosis in their area.
Rebecca Rennison, Target Ovarian Cancer’s Director of Public Affairs and Services, who will be leading the work said:
“Target Ovarian Cancer has been at the forefront of early diagnosis in ovarian cancer for over 10 years. This project is a first in ovarian cancer and will take a hands-on approach to improve early diagnosis. The government has set the ambitious target of 75 per cent of all cancers to be diagnosed at stage I or II by 2028 and this project will be a significant step towards meeting that in ovarian cancer.”
David Aspinall, Chair of the Peter Sowerby Foundation, said:
“The Peter Sowerby Foundation is delighted to fund this highly innovative Target Ovarian Cancer project. It is vital that CCGs and clinicians have the tools and support to make achievable and pragmatic changes that will ultimately lead to more women with ovarian cancer being diagnosed early. This project will save lives.”
For more info please click here.